Fundraising Fox

Max Kanevsky

Investor

Venture Partner at Excelerate Health Ventures

Greater Philadelphia

About

Former CTO at Certara and founder & CEO of Pinnacle 21, a clinical trial data validation standard acquired by Certara.

Experience

  1. Excelerate Health VenturesVenture Partnercurrent2025 β€” present
  2. CertaraAdvisor2024 β€” 2025
  3. CertaraChief Technology Officer2021 β€” 2024Radnor, Pennsylvania, United States
  4. Pinnacle 21 by CertaraFounder/CEO2011 β€” 2021Blue Bell, Pennsylvania, United States
  5. OpenCDISCFounder2008 β€” 2021
  6. IndependentConsultant2005 β€” 2011
  7. Regeneron PharmaceuticalsConsultant2008
  8. Merck & Co., IncClinical Data Exchange Specialist1999 β€” 2005

Education

  1. University of the Sciences in PhiladelphiaBS, Biochemistry1995 β€” 1999
  2. Drexel UniversityMS, Software Engineering2000 β€” 2005

Skills & more

Clinical Trials41Lifesciences4Validation12CDISC17Clinical Research10Clinical Development18Data Management26Biotechnology11Oncology8SDLC2FDA5GCP13
+10 moreLife SciencesCDISC StandardsSoftware Development Life Cycle (SDLC)U.S. Food and Drug Administration (FDA)CRO ManagementGood Clinical Practice (GCP)SASPharmaceutical IndustryCROSQL

From Max's professional profile.

Same school

Shared employers

Colleagues at Excelerate Health Ventures